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Abstract
Background: Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in Thailand occur most
frequently in healthcare facilities. However, reports of community-associated MRSA are limited.
Methods: We characterized 14 MRSA isolates from outpatients (O-1 to O-14) by phenotypic and genotypic
methods and compared them with 5 isolates from inpatients (I-1 to I-5). Thai MRSA isolates from a healthcare
worker (N-1) and a pig (P-1) were also included as ST9 MRSA strains from other sources.
Results: All MRSA isolates from the outpatients and inpatients were multidrug-resistant (resistant to ≥3 classes of
antimicrobials). All of them except strains O-2 and I-3 carried type III SCCmec and belonged to agrI, coagulase IV,
spa type t037 or t233, which related to ST239. The strain O-2 (JCSC6690) carried type IX SCCmec and belonged to
agrII, coagulaseXIc, spa type t337 and ST9, whereas the strain I-3 carried a type III SCCmec and belonged to ST1429.
Nucleotide sequence determination revealed that the type IX SCCmec element in strain O-2 was distinct from that
in a Thai ST398 strain (JCSC6943) previously identified in 2011; nucleotide identities of ccrA and ccrB were 93 and
91%, respectively and several open reading frames (ORFs) at the joining regions were different. PCR experiments
suggested that strain O-2 and N-1 carried similar SCCmec element, whereas that of strain P-1 was different,
suggesting that distinct ST9-MRSA–IX clones might be spreading in this province.
Conclusions: The SCCmecIX-ST9 MRSA clones of distinct SCCmec subtypes might have emerged in the Thai
community and might also have disseminated into the hospital.
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Background
Staphylococcus aureus is an important human pathogen
that causes a broad spectrum of infections, from mild
to life-threatening. The organism becomes methicillin-
resistant Staphylococcus aureus (MRSA) by acquiring
the mecA gene. Expression of the mecA results in pro-
duction of a special penicillin-binding protein, PBP2a,
which has reduced affinity to β-lactam antibiotics [1]
and confers resistance to all practically used β-lactam
antimicrobials. The mecA gene is usually carried on a
mobile genetic element called the staphylococcal cassette
chromosome mec (SCCmec), which contains two main
parts: the ccr gene complex (ccr) and the mec gene com-
plex (mec). The ccr gene complex comprises ccr gene (s),
ccrA and ccrB, or ccrC, which encode site-specific re-
combinases responsible for the mobility of SCCmec, and
surrounding open reading frames (ORFs). The mec gene
complex comprises the mecA gene, its regulatory genes,
and insertion sequences upstream or downstream of the
mecA gene [1]. SCCmec elements identified in S. aureus
have been classified according to the combination of ccr
allotypes with the mec gene complex: 11 types (I-XI)
have been reported to date [2,3].
MRSA strains were regarded to be pathogens that cause
hospital-acquired (HA) infections; however, MRSA infec-
tions in the community have been increasingly reported
[4,5]. MRSA strains that colonized or caused infections in
persons who meet the following criteria are considered to
be CA-MRSA: healthy persons; person with no prior
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history of a healthcare-associated risk factors such as a re-
cently (within the past year) hospitalized or had a medical
procedure (such as dialysis, surgery, catheters) [5,6]. Re-
cently, MRSA strains from livestock (e.g., pigs) or their
products have emerged throughout Europe, America and
Asia. Most of livestock-associated MRSA (LA-MRSA)
strains belonged to clonal complex (CC) 398 as defined by
multilocus sequence typing [7], although the other clones,
e.g., CC5, CC9, CC30, and CC97, have been occurred [8].
Most of MRSA infection in Thailand was hospital-
associated whereas CA-MRSA infection was very rare
[9]. The hospital-associated MRSA strains usually carried
types III or II SCCmec elements [10,11], while characteris-
tics of CA-MRSA strains were not fully investigated. We
aimed to characterize CA-MRSA strains disseminating in
the Thai community compared with HA-MRSA strains
from a teaching hospital in Thailand. Thai MRSA strains
from other sources such as hospital staff, pig were also in-
cluded and compared to a previously identified type IX
SCCmec MRSA strain from a Thai veterinarian [12].
Methods
Bacterial strains
MRSA isolates (O-1 to O-14) from 14 outpatients at
Srinagarind Hospital, Khon Kaen University, Thailand,
were collected between September 2005 and March
2006: 11 isolates from skin or tissue infection samples
and 3 from respiratory tracts. These strains met the cat-
egory of CA-MRSA since they were isolated from sam-
ples collected from the outpatient, who did not admit to
hospitals within a year. Five MRSA strains (I-1 to I-5)
isolated from inpatients >72 hours after admission were
also used as HA-MRSA control strains. In addition, 2
MRSA strains with type IX SCCmec (N-1 and P-1) were
examined to investigate distribution of MRSA clone in
the Thai community: the N-1 strain (isolated from a
nasal swab of a nurse) was chosen from 19 S. aureus
strains isolated during personnel surveillance in early
2006: the P-1 strain (from a pig with pneumonia) was
chosen from 4 S. aureus strains collected at the Vete-
rinary Research and Development Center of Upper
Northeastern Thailand in 2006.
All isolates were identified by conventional coagulase
and DNase tests. All of the MRSA strains from people
were taken as part of standard care.
This study was conducted in accordance with the dec-
laration of Helsinki and good clinical practice. It was ap-
proved by the Ethics Committee of Khon Kaen University
(project number HE551393).
Antimicrobial susceptibility test
The minimum inhibitory concentrations of 7 antimicro-
bials (vancomycin, cefazolin, oxacillin, cefoxitin, tetra-
cycline, erythromycin and ofloxacin) (Sigma Chemical,
St. Louis, USA) were determined using the agar dilution
method described by the Clinical and Laboratory Stan-
dards Institute [13]. S. aureus ATCC29213 was used as a
drug-susceptible standard strain.
Multiplex PCR for SCCmec type
Chromosomal DNA was extracted using the DNeasy tis-
sue Kit (Qiagen, Valencia, USA). Multiplex PCR for de-
tection of the mecA, ccr gene complex type and mec
gene complex class were performed using primer sets
and conditions as per Kondo et al. [14]. MLEP (mec left
extremity polymorphism) typing was performed to esti-
mate the insertion of SCCHg as per Ito et al. [15]. The S.
aureus strains used as reference strains for SCCmec typ-
ing were: NCTC10442 (type I), N315 (type II), 85/2082
(type III), MR108 (type IV), JCSC3624 (type V), and
HDE288 (type VI).
PCR identification for heavy metal resistance genes and
potential virulence genes
The mer operon and copA genes and genes encoding for
virulent factors such as exfoliative toxin type a, b, d (eta,
etb, etd), PVL (lukS-PV, lukF-PV) and TSST (tst) were
detected by PCR methods [15-17].
Molecular typing
Coagulase and agr typing was performed as per Sakai
et al. [18] and Shopsin et al. [19], respectively. Typing of
spa was performed as per Shopsin et al. [20]. The PCR
products of the spa genes were then purified using High
Pure PCR Product Purification kits (Roche Diagnostics,
Indianapolis, USA) and used as DNA templates for
sequencing by ABI PRISM 3100 (Applied Biosystems,
Foster City, USA). The designation of the spa type was
conducted using the RidomStaph Type program (www.
ridom.de).
Pulsed-field gel electrophoresis (PFGE) was conduc-
ted as a method for genotyping. The MSSA strain
NCTC8325 and MRSA strain N315 were used as refe-
rence strains for PFGE. The analysis of SmaI-digested
chromosomal DNA was performed using a contour-
clamped homogeneous electric field mapper system as
per the manufacturer’s instructions (Bio-Rad, Hercules,
USA), with a 48.5-kb ladder (Bio-Rad) as DNA-sized
markers. The PFGE patterns for all of the isolates were
analyzed using BioNumerics software (version 6.5; Ap-
plied Maths, Kortrijk, Belgium) and interpreted as per
Tenover et al. [21].
Multilocus sequence typing (MLST) was conducted as
per Enright et al. [22]. The alleles of the 7 loci were eval-
uated by comparing the sequences to those of the corre-
sponding loci in the S. aureus MLST database (www.
mlst.net). The sequence types (STs) were determined
according to the combined patterns of the 7 alleles,
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while the clonal complexes were defined using the BURST
program, based on related sequence types available on the
MLST website.
Determination of nucleotide sequences in and around the
SCCmec element and coa gene
We determined the entire nucleotide sequences of type IX
SCCmec carried by strain O-2 (JCSC6690) and nucleotide
sequences of coa genes that could not be identified by
PCRs using DNAs of three strains, O-2, N-1, and P-1. The
DNA fragments of the SCCmec element from the strain
O-2 and its genetics surrounding were amplified using
long-range PCRs (list of primers sets in Additional file 1:
Table S1). The region from Tn916 to copA gene was amp-
lified by using a constructed DNA template from the
Fosmid Library Production Kit (Epicentre Biotechnologies,
Madison, WI). The nucleotide sequences were determined
by primer-walking. The sequences were analyzed for ORFs
with the In Silico Molecular Cloning Program (IMC Load
command) and compared with the sequence databases
from the National Center for Biotechnology Information
using the basic local alignment search tool, BLAST
(National Library of Medicine, Bethesda, MD) for annota-
tion and prediction of functions. The nucleotide sequences
of the coa gene from strains O-2, N-1 and P-1 were deter-
mined as per Watanabe et al. [23].
PCR identification of ORFs at J3 regions of type IX
SCCmec elements
The carriage of ORFs at the J3 region of SCCmecIX ele-
ments was examined using chromosomal DNAs of
strains N-1 and P-1 with three sets of primers (sets a
and b as used for the strain O-2 and set c as used for
the strain JCSC6943) [12]. The locations and nucleotide
sequences of the primers used are indicated in Figure 1
and Additional file 1: Table S1, respectively.
Nucleotide sequence accession numbers
The respective nucleotide sequences of the two chromo-
somal regions containing the SCCmec element in strain
O-2 were deposited in the DDBJ/EMBL/GenBank data-
base under accession numbers AB705452 and AB705453.
The nucleotide sequences of three coa genes were depos-
ited in the DDBJ/EMBL/GenBank database under acces-
sion numbers AB742446 (strain O-2), AB742447 (strain
N-1) and AB787218 (strain P-1).
Results
Characteristics of MRSA isolates
All outpatient and inpatient MRSA strains were mul-
tidrug-resistant with high MIC values to cefazolin, oxa-
cillin, cefoxitin, tetracycline, erythromycin and ofloxacin
(32 - >64 μg/ml). However, all of them were still suscep-
tible to vancomycin.
None of the MRSA isolates carried the virulence-
related genes tested. Thirteen out of 14 outpatient iso-
lates and all 5 inpatient isolates carried a type 3 ccr gene
and class A mec gene complex, although 12 out of 13
outpatient isolates and 4 out of 5 inpatient isolates also
carried the ccrC. Further PCR experiments showed that
these 16 strains contained mercury resistance gene (mer)
and the extremity of SCCHg, therefore, they were identi-
fied as type III SCCmec strains carrying SCCHg [24]. In
conclusion, 18 out of 19 strains carried type III SCCmec.
The remaining strain, O-2, carried ccrA1B1 genes and
class C2 mec gene complex, which was categorized to
type IX SCCmec.
All isolates from both sources were of the agr group I
and coagulase type IV except for strain O-2 that belonged
to agr group II. Since the coagulase type of strain O-2
could not be determined neither by a genetic method
using multiplex PCRs nor by serological typing based on a
coagulation inhibition, its coagulase nucleotide sequences
Figure 1 Structural comparison of type IX SCCmec elements carried by strains O-2 and JCSC6943. Structures of SCCmec are illustrated
based on the nucleotide sequences deposited in databases DDBJ/EMBL/GenBank, under accession nos. AB505628 for JCSC6943, AB705452
(region 1, indicated by black bar) and AB705453 (region 2, indicated by black bar) for O-2. The red arrowhead indicates the location of ISS, and
the nucleotide sequences are given below. ORFs are colored as follows: yellow, insertion sequences; red, cad operons; lawn green, genes for
arsenical resistance operons; orange, copB; salmon, ORFs for ccr gene complexes. The three joining regions (J1, J2, and J3 regions) are indicated in
green. The locations of DNA fragments amplified with three pairs of primers (a, b, and c) are indicated in red bars. Nucleotide sequences of
primers used for amplification for three loci are listed in Additional file 1: Table S1.
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were determined, and classified into type XIc, a novel co-
agulase subtype. The majority of type III SCCmec strains
belonged to spa type t037 except for strains O-3 and I-3,
which belonged to spa type t233 and nontypeable, respect-
ively. No amplification product of spa-typing was seen
when used chromosomal DNA of strain I-3 as DNA tem-
plates. MLST genotypes of 5 spa t037 isolates, which were
chosen based on their unique PFGE banding patterns,
were identified as the ST239, whereas those of strain O-3
and I-3 were ST239 and ST1429 respectively. The strain
O-2 belonged to spa type t337 and ST9. The characteris-
tics of strain O-2 were distinct from other 18 strains.
The PFGE profiles revealed that 12 out of 14 out-
patient isolates showed similar banding patterns with 1–
2 different bands, while strains O-2 and O-3 had a dis-
tinct DNA profile (Figure 2). Three of the five inpatient
isolates showed closely related PFGE patterns and strain
I-3 belonging to ST1429 presented a distinct pattern,
whereas the band pattern of strain I-5 was related to the
outpatient strains (Figure 2).
Structure of type IX SCCmec in strain O-2 (SCCmecO-2)
The nucleotide sequences of the two long regions
containing SCCmec element in the strain O-2 were deter-
mined. The first 25 kb region contained a class C2 mec
gene complex, a type 1 ccr gene complex and the down-
stream end of a conjugative transposon, Tn916. The sec-
ond 32 kb region started from the upstream region of
Tn916 and ended at the extremity of an SCC. The overall
structure of the approximately 70-kb region from the
strain O-2 containing the SCCmec element and an SCC
without ccr gene (ΨSCC) is illustrated in Figure 1 and the
ORFs locating in these regions are listed in Table 1.
Three integration site sequences (ISS) comprising dir-
ectly repeated (DR) sequences were identified: the first
ISS, at the 3′ end of orfX; the second ISS, at the down-
stream of the copB gene on the 32-kb fragment; and the
third ISS, at the end of the 32 kb fragment (Figure 1).
The SCCmecO-2 was estimated to be 43 kb in size, in
which the Tn916 was integrated. At the downstream of
the SCCmec, an SCC encoding truncated ccrA1 had 83%
nucleotide identity with that of type I SCCmec in strain
NCTC10442.
We then compared the structure of SCCmecO-2 to a
previously reported type IX SCCmec of strain JCSC6943
[12]. The class C2 mec gene complexes of both strains
were highly identical, four ORFs around the mecA gene of
the strain O-2 had 100% identity with SCCmecJCSC6943.
The ccr gene complexes of both strains were located up-
stream to the mec gene complex. The nucleotide se-
quences of the ccrA1B1 in SCCmecO-2 showed 91–93%
identities with those of SCCmecJCSC6943 and 91–92%
identities with those of the type I SCCmec in strain
NCTC10442.
The ORFs at J3 region of SCCmecO-2 which encoded
for hypothetical proteins related to modification me-
thylase and restriction enzymes were less similar to
those of the JCSC6943 (Table 1). At the J1 region of
both SCCmec elements, the ORFs encoding resistance
genes for heavy metals (e.g., cadmium and copper) were
present. But a truncated copy of Tn916 encoding tetra-
cycline resistance gene (tetM) was identified only in the
SCCmecO-2 (Table 1).
Comparisons of type IX SCCmec MRSA isolates
The characteristic of type IX SCCmec MRSA strains,
N-1 and P-1, were compared with strain O-2. All 3
strains belonged to the same agr type and ST type
(Table 2). Nucleotide sequences of coa genes of these
three strains were exactly identical, which were classified
into type XIc. However, their spa types were not totally
identical. Strain P-1 belonged to spa type t044, whereas
strains N-1 and O-2 belonged to the same spa type t337.
These three isolates showed closely related PFGE pat-
terns with 2–4 different bands (Figure 2).
The carriage of genes in strains N-1 and P-1 examined
by using primer’s pairs (a, b and c) showed that strains
Figure 2 Dendrographic analysis of Pulsed-field Gel
Electrophoresis banding patterns of SmaI-digested
chromosomal DNAs of MRSA strains from human and a pig.
PFGE patterns of 14 MRSA strains from outpatients (O-1 to O-14), 5
MRSA strains from inpatients (I-1 to I-5), an MRSA strain from a
healthcare worker (N-1) and an MRSA strain from a pig (P-1) were
compared. Curve-based phylogenetic tree using Ranked Pearson
Correlation was generated using BioNewmerics.
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O-2 and N-1 were positive in PCRs using primer pairs a
and b, while strain P-1 was negative with all three
primer’s pairs. Although strains N-1 and P-1 were posi-
tive in PCRs identifying tetM and copB genes, the loca-
tions of these genes were not examined yet.
Discussion
Characteristics of type IX SCCmec in strain O-2
The SCCmecO-2, which was located on the downstream
region of the orfX, was classified into type IX. It had type
I ccr gene complex carrying ccrA and ccrB genes that
were classified into ccrA1 and ccrB1 based on the cri-
teria suggested by IWG-SCC [2]. The class C2 mec gene
complex of SCCmecO-2 was very similar to that of
SCCmecJCSC6943 [12], the ccr gene complex was lo-
cated between orfX and mec gene complex. Furthermore,
a number of ORFs encoding genes associated with heavy
metal resistance (i.e., cadD, cadX, arsC, arsB, arsR and
copB) were also found and showed 92-100% nucleotide
identities to those of the SCCmecJCSC6943. However, a
Table 1 ORFs of SCCmec in the S. aureus strain O-2 compared to S. aureus JCSC6943 and S. haemolyticus JCSC1435
ORFs Genes Description of products % identity to type IX SCCmec
in S. aureus JCSC6943a
% identity to
S. haemolyticus JCSC1435
KK01 orfx hypothetical protein 97 80
KK02 hypothetical protein, similar to modification methylase LlaFI <50 51.8
KK03 hypothetical protein, similar to[truncated]modification methylase LlaFI <50 50.3
KK04 hypothetical protein, similar to restriction enzyme LlaFI <50 <50
KK05 hypothetical protein 52 83
KK06 hypothetical protein 65 86.3
KK07 hypothetical protein 78 61.9
KK08 hypothetical protein 85 83
KK09 hypothetical protein <50 51.6
KK10 ccrB1 cassette chromosome recombinase B1 91 50
KK11 ccrA1 cassette chromosome recombinase A1 93 <50
KK12 hypothetical protein 81 51.1
KK13 hypothetical protein 61 <50
KK14 hypothetical protein 95 <50
KK15 tnp IS431 transposase 97.5 99.1
KK16 [truncated]putative HMG-CoAsynthase 100 83
KK17 Glycerophosphoryl diester phosphodiesterase 100 100
KK18 hypothetical protein 100 100
KK19 mecA penicillin-binding protein 2' 100 100
KK20 tnp transposase for IS431 100 98
KK21 tnp Tn916, transposase <50 <50
KK22 Tn916, hypothetical protein <50 <50
KK23 Tn916, transcriptional regulator <50 50
KK24 tetM tetracycline resistance protein TetM <50 <50
KK25 hypothetical protein <50 52.5
KK26 cadD cadmium binding protein 96 94
KK27 cadX cadmium resistant accessory protein 96 77
KK28 arsC arsenate reductase 93 82
KK29 arsB arsenic efflux pump protein 88 73
KK30 arsR arsenical resistance operon repressor 100 97
KK31 copA copper-exporting ATPase 98 67
KK32 putative lipoprotein 92 98
ORFs, KK1-KK24 and KK25-32 are from nucleotide sequences deposited at the DDBJ/EMBL/ GenBank databases under accession nos. AB705452 and
AB705453, respectively.
a % identities of less than 50% were expressed as <50%.
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Van Cefa Oxa Cefox Tetra Erythro Ofx
Isolates from outpatients (n = 14)
O-1 Pus Left thigh (Human) Accident, infected wound 2 > 64 > 64 > 64 32 > 64 > 64 ccrA3B3 A - - I IV t037 ST239
O-2 Pus Leftfoot (Human) Atopic dermatitis 1 32 32 32 > 64 > 64 > 64 ccrA1B1 C2 - + II XIc t337 ST9
O-3 Wound (Human) Electrical burn 2 > 64 > 64 > 64 64 > 64 > 64 ccrA3B3ccrC A + - I IV t233 ST239
O-4 Pus (Human) NA 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-5 Pus (Human) Infected wound 1 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + + I IV t037 NT
O-6 Tracheal suction (Human) NA 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 ST239
O-7 Sputum (Human) Pulmonary TB 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-8 Wound (Human) Accident, head injury 2 > 64 > 64 > 64 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-9 Wound (Human) Accident, infected wound 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-10 Pus Left cheek (Human) NA 1 > 64 > 64 > 64 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-11 Pus scalp (Human) Chronic scalp impetigo 2 > 64 > 64 > 64 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-12 Tissue (Human) Gas gangrene 2 > 64 > 64 > 64 32 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-13 Sputum (Human) NA 2 > 64 > 64 > 64 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
O-14 Pus Lt thigh (Human) Accident, infected wound 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 NT
Isolates from in patients (n = 5)
I-1 Blood (Human) NA 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3 A + - I IV t037 NT
I-2 Blood (Human) NA 1 > 64 > 64 > 64 > 64 16 > 64 ccrA3B3ccrC A + - I IV t037 NT
I-3 Blood (Human) NA 1 > 64 > 64 > 64 8 > 64 > 64 ccrA3B3ccrC A + + I IV UDc ST1429
I-4 Sputum (Human) NA 2 > 64 > 64 > 64 > 64 > 64 > 64 ccrA3B3ccrC A + - I IV t037 ST239
I-5 Sputum (Human) NA 2 > 64 > 64 > 64 32 > 64 > 64 ccrA3B3ccrC A - - I IV t037 ST239
An isolate from healthy worker (n = 1)
N-1 Nasal swab (Human) colonize 1 > 64 64 32 64 1 > 64 ccrA1B1 C2 - + II XIc t337 ST9
An isolate from pig (n = 1)
P-1 Lung (pig) pneumonia 1 > 64 > 64 64 > 64 64 > 64 ccrA1B1 C2 - + II XIc t044 ST9
a O, outpatient; I, inpatient; N, nurse; P, pig; NA, information was not available.
b Van, vancomycin; Cefa, cefazolin; Oxa, oxacillin; Cefox, cefoxitin; Tetra, tetracycline; Erythro, erythromycin; Ofx, ofloxacin.



















number of ORFs were absent in the SCCmecJCSC6943,
e.g., hypothetical proteins related to restriction-modifi-
cation system at J3 region and a conjugative transposon
Tn916 encoding tetM at J1 region. The transposon
Tn916 was located just downstream of the class C2 mec
gene complex and the extremity of Tn916 including int
gene was truncated. The transposition of Tn916 was not
site-specific. We presume that Tn916 transposed firstly
into the SCC element, then the class C2 mec gene com-
plex was integrated to the SCC harboring Tn916 by
disrupting its extremity.
The class C2 mec gene complex was formerly reported
predominantly in S. haemolyticus [1]. Comparison of the
ORFs of SCCmecO-2 and those of S. haemolyticus strain
JCSC1435 revealed that their heavy metal-resistant genes
(e.g., cadD, cadX, arsC, arsB, arsR, copB) had 67-97%
identities. Three ORFs at the J3 region had more than
80% identities with those of the S. haemolyticus strain
JCSC1435 [25]. These data suggested that although the
SCCmecO-2 and SCCmecJCSC6943 were classified into
type IX, they might have evolved independently. Further
study will clarify whether any staphylococcal strains such
as the S. haemolyticus, might serve as reservoirs for SCC
or SCCmec elements (Table 1).
MRSA clones in Thailand
MRSA infections in the hospitals have been a big con-
cern in Thailand. So far the HA-MRSA strains have
been analyzed, ST239-SCCmecIII clone was the major,
although ST5-SCCmecII clone was identified as the
minor one [10,11]. On the other hand, CA-MRSA in
Thailand was reported to be very rare [9]. The incidence
of CA-MRSA was undetermined because most outpa-
tients with non severe infections were treated empiric-
ally without collecting samples for culture [26]. Most of
the MRSA isolates from outpatients in the present study
were ST239-SCCmecIII-spa type t037, which was the
dominant clone reported in Asian countries except for
Korea and Japan [10]. CA-MRSA has been reported to
be susceptible to a wide range of non-β-lactam antibi-
otics, low oxacillin MIC, but our tested strains were
multidrug-resistant to non-β-lactam antimicrobials simi-
lar to HA-MRSA strains [27].
Our results were consistent with the report from
ANSORP that ST239-SCCmecIII and ST5-SCCmecII
MRSA clones were found among CA-MRSA isolates
from patients in Asian countries (e.g., Vietnam, Thailand,
Sri Lanka, Taiwan, and Hong Kong), without any risk
factors for HA-MRSA infection [5]. The results of our
PFGE experiment suggested that ST239–SCCmecIII
strains disseminated in the community were rather clo-
nal and distinct from those in the hospital. Further de-
tailed study will be needed to clarify this hypothesis.
A novel MRSA clone in the Thai community
It has been reported that CA-MRSA strains tend to
carry types IV or V SCCmec element and belonged
to particular genotypes. The distribution of CA-MRSA
clones varied by geographical area: the ST1-SCCmecIV
and ST8-SCCmecIV strains (called as USA400 and
USA300 based on PFGE patterns) in the USA; the
CC80-SCCmecIV strains in Europe and Africa; ST22-
SCCmecIV and SCCmecV- ST772 strains in India; ST30-
SCCmecIV and ST93-SCCmecIV strains in Australia; and
CC59-SCCmecV strains in Asia [28,29]. Interestingly,
most of these CA-MRSA strains carried the Panton Val-
entine Leukocidin (PVL) gene that encodes a necrotizing
cytotoxin, which may be responsible for the invasiveness
and virulence of the organism [30]. Recently livestock
associated MRSA (LA-MRSA) have emerged in the
community and spread into hospitals [31-34]. The ma-
jority of LA-MRSA strains belonged to ST398, while
strains belonged to other STs, e.g. ST9, has also been
reported.
In this study, we analyzed three ST9 MRSA strains
carrying SCCmecIX, the same SCCmec type identified in
an ST398-MRSA isolated from a Thai veterinarian
(strain JCSC6943) [12].
The strain O-2 was isolated in March 2006, from a
young boy with underlying atopic dermatitis and suffer-
ing from chronic impetigo of the left foot. He had not
been admitted to hospital in the prior year. Therefore,
we regarded the strains as CA-MRSA and as a novel
MRSA clone emerged in the Thai community. We ex-
plored the clone and identified 2 strains, one (strain P-1)
from a diseased pig with pneumonia in the same prov-
ince and the other (strain N-1) from a nasal swab of a
nurse isolated during hospital-personnel surveillance in
the same year as the first case. The ST9-MSSA has occa-
sionally been isolated from healthy human carriers [35]
and has been able to colonize and be transmitted be-
tween humans and pigs as it has also been isolated from
pigs and workers on pig farms [36,37]. Recently ST9-
SCCmecIX strains have been isolated from swine in
Thailand [38,39]. In the present study, 2 isolates of ST9-
SCCmecIX were from humans. To our knowledge, this
is the first report of ST9-SCCmecIX strain from humans
(a patient and a healthy healthcare worker) and a dis-
eased pig in Thailand. Unfortunately, information re-
garding any animal contact by these persons or their
families was not available. The ST9-SCCmecIX strain
would belong to a newly identified CA-MRSA clone dis-
seminating in the Thai community, although no isolate
harbored any potential virulence genes including the pvl
gene, which is usually found in CA-MRSA strains.
The detailed comparison of 3 ST9-SCCmecIX strains:
O-2, N-1, and P-1, suggested that strains isolated from
human and pig were not exactly identical. Their PFGE
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patterns were not totally identical but they were closely
related, in contrast, that of ST398 strain JCSC6943
showed a non-typeable pattern (absence of DNA frag-
ment). The spa type of strains O-2 and N-1 belonged to
t337, whereas strain P-1 belonged to t044. Recently,
MRSA isolates from pigs and pork in Thailand carrying
the SCCmecIX-spa type t337 have been reported [38,39].
The ST9-spa type t899 MRSA and MSSA were recently
isolated from dust samples taken from Chinese pig farms
[40]. Most of these isolates were resistant to various
classes of antimicrobials such as ß-lactams, macrolides
and tetracycline, which is consistent with the strains O-2,
N-1 and P-1. However, those strains belonged to the
SCCmec type III.
PCR identification of J regions in strains O-2 and N-1
suggested that they carried the same subtype of type IX
SCCmec, which was distinct from that of strain P-1 and
JCSC 6943. On the other hand, strain P-1 was assumed to
carry a novel subtype of type IX SCCmec, since it was dis-
tinct from that of strains O-2 and JCSC6943. We presume
that livestock, e.g., pigs, might be the reservoir of ST9-
S. aureus in Asian countries. The ST9-S. aureus strain
might become an MRSA by acquiring SCCmec elements
from different sources, since ST9-SCCmecIII strains were
identified in China [40]. Identification of several subtypes
of type IX SCCmec elements suggested that such elements
might come from elsewhere and integrated into ST9
strains. In this study, it could not be concluded that
SCCmecIX strains from human were derived from pig,
since strain P-1 was not identical to strains O-2 and N-1.
However, SCCmecIX strains with the same spa type (t337)
have been identified from pigs (38, 39). Further study of
these isolates will clarify whether ST9 MRSA strains iso-
lated from human might be derived from livestock and
disseminated in the Thai community.
Conclusions
ST9-SCCmecIX MRSA strains from humans (a patient
and a healthy healthcare worker) and a diseased pig in
Thailand were reported as a newly identified CA-MRSA
clone disseminating in the Thai community.
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